Key Takeaways Clorox is set to report 2Q26 results on Feb. 3, with revenue and EPS expected to decline year over year.CLX faces elevated manufacturing, logistics and trade promotion costs, pressuring margins amid inflation.Clorox leans on brand strength, IGNITE execution and a near-complete ERP rollout to support recovery.The Clorox Company (CLX) is slated to report second-quarter fiscal 2026 earnings on Feb. 3, after market close. The company is expected to register year-over-year top and bottom-line decli ...

Core Viewpoint - Clorox Company (CLX) is expected to report significant year-over-year declines in both revenue and earnings for the first quarter of fiscal 2026, primarily due to ERP-related disruptions and macroeconomic challenges [1][3][5]. Revenue and Earnings Estimates - The Zacks Consensus Estimate for fiscal first-quarter revenues is $1.39 billion, reflecting a 21.2% decline from the previous year [2][9]. - The consensus estimate for earnings per share (EPS) has decreased to 78 cents, indicating a 58.1% drop compared to the same quarter last year [2][9]. Operational Challenges - Clorox is facing a challenging start to fiscal 2026, with significant headwinds from ERP-related disruptions and a reduction in retailer inventory built up in late fiscal 2025 [3][4]. - The company anticipates that these ERP transition effects will account for a 14-15 point decline in sales and 200 basis points of margin pressure in the first quarter [4][6]. Margin and Profitability Outlook - Gross margin is projected to be between 41% and 42%, which is below historical levels, primarily due to 200 basis points of pressure from the ERP transition and an additional 100 basis points from storm-related damages [7][9]. - Adjusted operating profit is expected to decline by 50.1% year over year to $165.5 million, with an adjusted operating margin contracting to 11.8% [9]. Market Environment - Clorox operates in a challenging macroeconomic environment, facing increased advertising expenses and stiff competition in the consumer goods sector, which pressures market share and operational performance [8][9]. - The company is also dealing with early impacts of tariffs and elevated selling, general, and administrative (SG&A) costs [8]. Future Outlook - Management remains optimistic about a recovery in the second half of the year as consumption stabilizes and ERP-related effects diminish [5][9]. - Clorox is nearing completion of a multi-year digital transformation, which is expected to enhance supply-chain responsiveness and operational efficiency [12][13].

Core Insights - The Clorox Company (CLX) reported strong fourth-quarter fiscal 2025 results, with both revenue and earnings exceeding expectations and showing year-over-year growth [1][3][4] - The company is advancing its long-term strategy with the rollout of a new U.S. enterprise resource planning (ERP) system aimed at enhancing growth and efficiency [2][15] Financial Performance - Adjusted earnings per share (EPS) reached $2.87, surpassing the Zacks Consensus Estimate of $2.24, marking a 57.7% increase from $1.82 in the same quarter last year [3] - Net sales totaled $1.99 billion, a 4.5% increase year-over-year, driven by an 8-point increase in volume, partially offset by a 4-point decline in price mix [4] - Organic sales grew by 8% year-over-year [4] Segment Performance - The Health and Wellness segment saw a 14% increase in sales to $741 million, driven by an 18-point increase in volume [6] - The Household segment reported a 7% increase in net sales to $639 million, with a 13-point increase in volume [7] - The Lifestyle segment's sales grew by 3% to $339 million, reflecting an 8-point increase in volume [8] - The International segment experienced a 1% decline in net sales to $269 million, despite a 5-point increase in volume [9] Gross Profit and Margins - Gross profit increased by 4.5% year-over-year to $924 million, with a gross margin remaining flat at 46.5% [5] - Incremental ERP shipments contributed approximately 150 basis points to gross margin [5] Future Guidance - For fiscal 2026, net sales are expected to decline by 6% to 10%, with organic sales anticipated to decrease by 5% to 9% due to the reversal of incremental shipments from the previous year [16][19] - Adjusted EPS is projected to be between $5.95 and $6.30, indicating a decline of 18% to 23% from the previous year [20]